Samoa Wellness Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Samoa Wellness Report.

Press releases published on July 30, 2026

3 hours ago

Tvardi Therapeutics Selects Ulcerative Colitis as Initial Indication for TTI-109

Indeterminate GlobeNewswire

3 hours ago

PharmAla Issues Q3 Financial Statements and AGM Update

Indeterminate GlobeNewswire

3 hours ago

InflaRx to Report Second Quarter 2026 Results on August 6, 2026

Indeterminate GlobeNewswire

3 hours ago

Palvella Therapeutics Chief Scientific Officer Jeff Martini, Ph.D. Selected to Present at Upcoming FDA Public Workshop on Drug Repurposing

Indeterminate GlobeNewswire

3 hours ago

Alterity Therapeutics Releases Appendix 4C – Q4 FY26 Quarterly Cash Flow Report & Corporate Update

Indeterminate GlobeNewswire

4 hours ago

Immunocore to report second quarter 2026 financial results and host call on August 6, 2026

Indeterminate GlobeNewswire

4 hours ago

INmune Bio Establishes Scientific Advisory Board to Support Late-Stage Development and Expansion of CORDStrom™ Platform

Indeterminate GlobeNewswire

4 hours ago

Atavistik Bio Partners with Cure HHT Clinical Trial Network to Advance Development of ATV-1601 for Hereditary Hemorrhagic Telangiectasia

Indeterminate GlobeNewswire

4 hours ago

EyePoint Completes Enrollment of Both Pivotal Phase 3 Trials of DURAVYU™ for Treatment of Diabetic Macular Edema (DME)

Indeterminate GlobeNewswire

4 hours ago

Madrigal Pharmaceuticals Reports Second-Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire

4 hours ago

Mangoceuticals Announces Business Combination Agreement with Nuclea Energy Inc. to Advance Next-Generation Nuclear Microreactor Technology

Indeterminate GlobeNewswire

4 hours ago

Beyond Air® Announces Up to $30.1 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules

Indeterminate GlobeNewswire

4 hours ago

HUTCHMED Reports 2026 Interim Results

Indeterminate GlobeNewswire

4 hours ago

Phathom Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

4 hours ago

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Completes Patient Enrollment in Phase II Study for Biliary Tract Cancer, Further Demonstrating Breakthrough Potential in Immune-Cold Tumors

Indeterminate GlobeNewswire

4 hours ago

Agios Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

4 hours ago

Regeneron Reports Second Quarter 2026 Financial and Operating Results

Indeterminate GlobeNewswire

5 hours ago

Cytokinetics Announces MHRA Marketing Authorisation for MYQORZO®▼ (aficamten) and Positive Guidance from NICE for Symptomatic Obstructive Hypertrophic Cardiomyopathy in England and Wales

Indeterminate GlobeNewswire

5 hours ago

Amneal Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

6 hours ago

Questex’s Fierce Pharma announces launch of Fierce Pharma Week Europe in Basel, Switzerland in June 2027

Indeterminate GlobeNewswire